News by subject: ERN

Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) is pleased to announce the results of Operations for the Three Months and Quarter Ending June 30, 2023.  Revenues for the quarter ending June 30, 2023 ("Q2 2023") were $322,827...

Inhibikase Therapeutics, Inc. (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of...

Greenlane Renewables Inc. ("Greenlane" or the "Company") today announced its financial results for the second quarter ended June 30, 2023. For further information on these results please see the Company's Condensed Consolidated Interim Financial...

Big Rock Brewery Inc. ("Big Rock" or the "Corporation") today announced its financial results for the three months ended June 30, 2023....

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal...

QuickLogic Corporation ("QuickLogic" or the "Company"), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI solutions, today announced its financial results for the fiscal second quarter ended July 2, 2023....

Two near-term data catalysts expected in 2023 Entered active collaboration with Alvogen Pharmaceuticals and Lotus Pharmaceuticals for global development and commercialization of NRX-101 in suicidal bipolar depression; potential for up to $330 million...

Pioneer Power Solutions, Inc. ("Pioneer", "Pioneer Power" or the "Company"), a leader in the design, manufacture, service and integration of electrical power systems, distributed energy resources, power generation equipment and mobile electric...

Spark Networks SE (the "Company"), a leading social dating platform for meaningful relationships, today reported financial results for its second quarter ended June 30, 2023....

Senmiao Technology Limited ("Senmiao") , a financing and servicing company focused on the online ride-hailing industry in China, as well as an operator of its own online ride-hailing platform, today announced financial results for its fiscal 2024...

Inpixon® , a leading provider of real-time location systems (RTLS), today provided a business update and reported financial results for the second quarter ended June 30, 2023....

GSE Systems, Inc. ("GSE Solutions", "GSE", or "the Company") , a leader in advanced engineering and workforce solutions that support the future of clean energy production and decarbonization initiatives of the nuclear power industry, today announced...

Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the second quarter ended June 30, 2023. Francisco Salva, Chief Executive Officer of...

Heron Therapeutics, Inc. ("Heron" or the "Company"), a commercial-stage biotechnology company focused on improving...

PhenomeX, Inc. , a life sciences tools company, today reported financial results for the second quarter ended June 30, 2023. Recent...

Today, Movano Health , a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months ending June 30, 2023 and provided a business update....

Elevation Gold Mining Corporation (the "Company" or "Elevation Gold") is pleased to announce financial results for three and six months ended June 30, 2023. All figures are expressed in US dollars unless otherwise noted....

Cineverse Corp. ("Cineverse" or the "Company") , a global streaming technology and entertainment company, today announced its financial results for the fiscal first quarter ended June 30, 2023 ("Q1 FY 2024"). ...

FG Acquisition Corp. (the "Company") today reported its interim financial results as at and for the three and six months ended June 30, 2023. The Company's unaudited interim financial statements along with its management discussion and analysis have...

INVO Bioscience, Inc. ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today...

Eiger BioPharmaceuticals, Inc. , a commercial-stage biopharmaceutical company focused on the development of innovative...

Quantum Computing Inc. initiates commercialization during first half of 2023 and commenced multiple product launches year-to-date, including: Dirac Series Entropy Quantum computer.Zero-Trust Cyber Security Protection solution.Non-repeatable Quantum...

Remark Holdings, Inc. , a diversified global technology company with leading artificial intelligence ("AI") solutions and digital video analytics, today announced its financial results for its second quarter fiscal 2023 ended June 30, 2023. For...

Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, today reported business highlights and financial results for the...

Moatable, Inc. ("Moatable" or the "Company"), which operates two US-based SaaS businesses, Chime Technologies Inc.© and Trucker Path Inc.©, today reported its second quarter 2023 financial results. Second Quarter 2023 Financial Highlights Revenue...

Arcellx, Inc. , a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced the U.S. Food and Drug Administration (FDA) has lifted the...

Emmaus Life Sciences, Inc. , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three and six months ended June 30,...

Expects to Eliminate Remaining $22 Million of Secured Debt by Selling South Carolina Mining Site to NYDIG Greenidge Expects to Receive $4.9 million of Cash, Less Certain Costs, with Potential to Earn up to $2.6 million Additional Cash in Bonus...

Vocal, Inc., a subsidiary of Creatd, Inc., bolsters its tech platform's standing in the creator economy and plans to secure funding for expansion through direct investment.Creatd announces it will file Q2 2023 gross revenues of $800,000, coupled with...

International Isotopes Inc. (the "Company" or "INIS") announces its financial results for the three- and six-month periods ended June 30, 2023. Revenue for the six months ended June 30, 2023, was $6,201,700 compared to $5,242,249 for the...

CV Sciences, Inc. (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for...

Lifeway Foods, Inc. ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today reported financial results for the second quarter ended June...

Nagarro's superior client experience and its strategic diversification continued to deliver resilient growth in the face of global economic uncertainties. In Q2 2023, revenue grew to ?226.8 million, up 8.0% YoY from ?210.0 million in Q2 2022....

EMBRAER S.A. releases its SECOND Quarter 2023 Earnings Results. HIGHLIGHTS Embraer delivered 47 jets in the second quarter, of which 17 commercial aircraft and 30 executive jets (19 light and 11 mid-size). A strong increase of 47% in total...

IM Cannabis Corp. (the "Company" or "IMC") , an international medical cannabis company, announced its financial results today for the second quarter ended June 30, 2023. All amounts are reported in Canadian dollars and compared to Q2 2022 unless...

GreenPower Motor Company Inc. ("GreenPower" and the "Company"), a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and...

IceCure Medical Ltd. ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative...

?On Track to Achieve CM-101 PSC Phase 2 Readout Expected in 2H2024? ?Extended Estimated Cash Runway Through PSC Readout and 2024 Year-End? ?Reported Positive Secondary Analysis of Data from CM-101 Phase 2 Liver Fibrosis Trial? ?Successfully...

Auxly Cannabis Group Inc.  ("Auxly" or the "Company") today released its financial results for the three and six months ended June 30, 2023. These filings and additional information regarding Auxly are available for review on SEDAR at www.sedar.com....

Invesque Inc.  (the "Company") today announced its results for the three and six months ended June 30, 2023. Second Quarter and Subsequent Highlights The Company had a busy second quarter, continuing to streamline and strengthen the portfolio...

Taiga Motors...

MediPharm Labs Corp. ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial results for the three months ended June 30, 2023....

BrainStorm Cell...

Closed Upsized IPO Priced at Top-Of-Range, Full Exercise of the Over-Allotment Nets $20.4 Million in Proceeds Data Presented at ASCO Showed that Lead Asset INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with...

Acurx Pharmaceuticals, Inc.  ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and operational results for the...

Perpetua Resources Corp.  ("Perpetua Resources" or "Perpetua" or the "Company") announced today that its unaudited condensed consolidated financial results for the period ended June 30, 2023 were filed. For details, please see the Company's filings...

Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced financial results for its...

Arlington Asset Investment Corp. (the "Company," "Arlington," "we," "us" or "our") today reported financial results for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights $6.64 per common share of book value, a 2.6% increase...

Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for second quarter ended June 30, 2023. Leap Highlights:  Announced that initial data from Part A of...

Karora Resources Inc. ("Karora" or the "Company") today announced financial and operating results for the second quarter ("Q2 2023") and first six months ("YTD 2023") of 2023. The Company's full unaudited condensed interim financial statements and...